Delaware | 33-0628076 | |
(State of incorporation or organization) | (I.R.S. Employer | |
Identification No.) | ||
One Enterprise | ||
Aliso Viejo, California | 92656 | |
(Address of principal executive offices) | (Zip Code) |
If this form relates to the
registration of a class of
securities pursuant to Section 12(b)
of the Exchange Act and is effective
pursuant to General Instruction
A.(c), please check the following
box. þ
|
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. o |
Title of each class to be so registered |
Name of each exchange on which each class is to be registered |
Common Stock, par value $.01 per share (and
associated Preferred Stock Purchase Rights)
|
New York Stock Exchange |
Item 1. Description of Registrants Securities to be Registered | ||||||||
Item 2. Exhibits | ||||||||
SIGNATURE | ||||||||
INDEX TO EXHIBITS | ||||||||
EX-4.4 |
3.1
|
Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Companys Form 10-Q for the quarter ended September 30, 2003, filed by the Company on November 12, 2003). | |
3.2
|
Certificate of Designation, Preferences and Rights of Series A Participating Preferred Stock (incorporated by reference to Exhibit 3.1 of the Companys Current Report on Form 8-K, dated October 5, 2004, filed by the Company on October 6, 2004). | |
3.3
|
Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Companys Current Report on Form 8-K, dated February 20, 2008, filed by the Company on February 25, 2008). | |
4.1
|
Form of Rights Agreement, dated as of November 2, 1994, by and between Valeant Pharmaceuticals International and American Stock Transfer & Trust Company, as Rights Agent (incorporated by reference to Exhibit 4.3 to the Companys Registration Statement on Form 8-A, filed by the Company on November 10, 1994). | |
4.2
|
Amendment No. 1 to Rights Agreement, dated as of October 5, 2004, by and between Valeant Pharmaceuticals International and American Stock Transfer & Trust Company, as Rights Agent (incorporated by reference to Exhibit 4.2 to the Companys Current Report on Form 8-K, filed by the Company on October 6, 2004). | |
4.3
|
Amendment No. 2 to Rights Agreement, dated as of June 5, 2008, by and between Valeant Pharmaceuticals International and American Stock Transfer & Trust Company, as Rights Agent (incorporated by reference to Exhibit 4.3 to Amendment No. 4 to the Companys Registration Statement on Form 8-A/A, filed by the Company on June 6, 2008). | |
4.4
|
Amendment No. 3 to Rights Agreement, dated as of May 15, 2009, by and between Valeant Pharmaceuticals International and American Stock Transfer & Trust Company, as Rights Agent. |
VALEANT PHARMACEUTICALS INTERNATIONAL |
||||
By: | /s/ Steve T. Min | |||
Steve T. Min | ||||
Executive Vice President, General Counsel | ||||